GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » Other Cash Payments from Operating Activities

Trillium Therapeutics (Trillium Therapeutics) Other Cash Payments from Operating Activities


View and export this data going back to 2009. Start your Free Trial

What is Trillium Therapeutics Other Cash Payments from Operating Activities?

Other Cash Payments from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Trillium Therapeutics (Trillium Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » Other Cash Payments from Operating Activities
Traded in Other Exchanges
N/A
Address
100 CambridgePark Drive, Suite 510, Cambridge, MA, USA, 02140
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.